Holocene Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,485,056
| Closed | -$15.4M | – | 700 |
|
|
2023
Q2 | $15.4M | Hold |
1,485,056
| – | – | 0.07% | 223 |
|
|
2023
Q1 | $12M | Sell |
1,485,056
-178,619
| -11% | -$1.45M | 0.06% | 223 |
|
|
2022
Q4 | $26.2M | Sell |
1,663,675
-397,243
| -19% | -$6.26M | 0.16% | 156 |
|
|
2022
Q3 | $32.4M | Hold |
2,060,918
| – | – | 0.21% | 140 |
|
|
2022
Q2 | $28.8M | Hold |
2,060,918
| – | – | 0.17% | 158 |
|
|
2022
Q1 | $35.5M | Buy |
2,060,918
+2,300
| +0.1% | +$39.7K | 0.19% | 145 |
|
|
2021
Q4 | $29.9M | Buy |
2,058,618
+103,013
| +5% | +$1.5M | 0.16% | 165 |
|
|
2021
Q3 | $35.2M | Buy |
1,955,605
+557,233
| +40% | +$10M | 0.19% | 144 |
|
|
2021
Q2 | $24.6M | Buy |
1,398,372
+872,509
| +166% | +$15.3M | 0.14% | 161 |
|
|
2021
Q1 | $13.3M | Buy |
+525,863
| New | +$13.3M | 0.08% | 199 |
|